Get the Daily Brief
Latest Biotech News
Nobel Prize Awarded for Peripheral Immune Tolerance Discoveries
The 2025 Nobel Prize in Physiology or Medicine has been jointly awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their seminal discoveries on regulatory T cells (Tregs) and their...
Skye Bioscience Obesity Drug Fails Mid-Stage Trial, Shares Plummet
Skye Bioscience’s cannabinoid receptor 1 (CB1) antagonist, nimacimab, failed to achieve significant weight loss compared to placebo in a mid-stage clinical trial involving overweight and obese...
FDA Pilots Program to Accelerate Domestic Generic Drug Manufacturing
The U.S. Food and Drug Administration (FDA) has launched a pilot initiative to expedite the approval process for generic drugs manufactured domestically with active pharmaceutical ingredients...
AstraZeneca and Algen Biotechnologies Ink $555M AI-Driven Drug Discovery Deal
AstraZeneca and San Francisco-based Algen Biotechnologies have entered a strategic collaboration worth up to $555 million, leveraging Algen’s AI-powered AlgenBrain platform that integrates...
Aerska Emerges with $21M to Develop RNAi Neurological Therapeutics
Dublin-based biotech Aerska has publicly emerged from stealth mode following a $21 million financing round aimed at advancing its platform for RNA interference (RNAi) therapeutics targeting...
Illinois Health Biotechnology Booms with Supportive Ecosystem and Policy
Illinois has solidified its position as a fast-growing biotech hub, with over 93,000 life sciences workers earning an average salary of $153,000, growing at 7.5% annually since 2019—20 times...
Cancer Drug Datroway Shows Phase 3 Promise in Triple-Negative Breast Cancer
AstraZeneca and Daiichi Sankyo have reported positive Phase 3 clinical trial results for Datroway (their novel antibody-drug conjugate) in treatment of hard-to-treat triple-negative breast cancer...
Regencell Bioscience’s Stock Surges and Crashes Amid Speculative Frenzy
Regencell Bioscience Holdings, a Hong Kong-based biotech focusing on Traditional Chinese Medicine (TCM) herbal formulas for neurocognitive disorders, witnessed unprecedented stock volatility in...
Advancements in Nursing: Intelligent Frameworks and Patient-Centered Care
Recent research highlights innovative developments in nursing care methodology. One study introduces a digital intelligent precise nursing framework designed to enhance patient outcomes through...
Emerging Research on Depression Mechanisms and Mental Health Pathways
Groundbreaking studies have identified novel molecular mechanisms underlying depression and its connection to brain biochemistry. One pivotal study reveals that abnormal sugar protein...
Nobel Prize Awarded for Peripheral Immune Tolerance Discoveries
The 2025 Nobel Prize in Physiology or Medicine has been awarded jointly to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their seminal work on peripheral immune tolerance. Their...
CareDx Achieves IVDR Certification Advancing Transplant Diagnostics
CareDx has secured IVDR certification from the European Union for its AlloSeq Tx and QType next-generation sequencing and RT-PCR-based HLA typing products. These platforms enhance compatibility...
Skye Bioscience’s CB1 Antibody Fails Obesity Trial, Shares Plunge
Skye Bioscience announced the failure of its obesity drug nimacimab—an antibody targeting cannabinoid receptor 1 (CB1)—to achieve significant weight loss in a phase 2 trial. Nimacimab monotherapy...
Algen Biotechnologies and AstraZeneca Forge $555M AI-Driven Immunology Pact
Algen Biotechnologies and AstraZeneca announced a drug discovery partnership valued at up to $555 million. The collaboration leverages Algen's AlgenBrain platform, which integrates single-cell...
Regencell Bioscience’s Stock Soars Amid Retail Frenzy, Then Crashes
Regencell Bioscience Holdings, a Hong Kong-based early-stage biotech focused on traditional Chinese medicine for neurocognitive disorders, experienced extraordinary stock volatility in 2025....
Cancer Research: New Mechanisms in Breast and Colorectal Oncology Revealed
Recent studies have identified key molecular drivers in major cancers. Research on colorectal cancer reveals that loss of the HUWE1 ubiquitin ligase promotes stemness and drug resistance by...
Advances in Pediatric Clinical Research and Neonatal Care
Several pivotal pediatric health developments surface. A novel clinical tool dramatically improves pediatricians' adherence to peanut allergy prevention guidelines by a factor of 15, heralding a...
Cytiva’s Global Biopharma Index Reveals Talent Crunch, Regulatory Challenges
Cytiva’s 2025 Global Biopharma Index highlights declining ecosystem resilience with an average score dip to 5.96 from 6.08 in 2023. The report notes improved supply chain robustness but continuing...
Advances in Computational Biology and Machine Learning for Drug Discovery
Breakthroughs in computational biology drive new frontiers in drug discovery and protein design. The DeepMice model introduces multilevel mapping to optimize protein-ligand docking, improving...
Pfizer’s Deal with US Administration Spurs Stock Surge and Manufacturing Pledge
Pfizer’s accord with the Trump administration, securing a three-year tariff grace period amid commitments to expand U.S. manufacturing and apply most favored nation (MFN) pricing to Medicaid...